GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Accumulated other comprehensive income (loss)

IDEXX Laboratories (BSP:I1DX34) Accumulated other comprehensive income (loss) : R$-400 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. IDEXX Laboratories's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was R$-400 Mil.

IDEXX Laboratories's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (R$-370 Mil) to Dec. 2023 (R$-349 Mil) but then declined from Dec. 2023 (R$-349 Mil) to Mar. 2024 (R$-400 Mil).

IDEXX Laboratories's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (R$-302 Mil) to Dec. 2022 (R$-408 Mil) but then increased from Dec. 2022 (R$-408 Mil) to Dec. 2023 (R$-349 Mil).


IDEXX Laboratories Accumulated other comprehensive income (loss) Historical Data

The historical data trend for IDEXX Laboratories's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Accumulated other comprehensive income (loss) Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -189.55 -275.83 -302.45 -408.07 -348.90

IDEXX Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -399.06 -357.55 -369.86 -348.90 -400.36

IDEXX Laboratories Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


IDEXX Laboratories Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (BSP:I1DX34) Business Description

Industry
Traded in Other Exchanges
Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines